Drug: vincristine Quarter: 2016Q3
Total Records: 1,179 Number of Pages: 59
DRUGNAME | PT | EventCount |
---|---|---|
VINCRISTINE SULPHATE | Pyrexia | 1 |
VINCRISTINE SULPHATE | Thrombocytopenia | 1 |
VINCRISTINE TEVA | Acute respiratory distress syndrome | 1 |
VINCRISTINE TEVA | Febrile bone marrow aplasia | 1 |
vincristine Teva | Follicle centre lymphoma, follicular grade I, II, III recurrent | 1 |
VINCRISTINE TEVA | Hepatitis acute | 1 |
Vincristine Teva | Hypertension | 1 |
VINCRISTINE TEVA | Lung disorder | 1 |
vincristine Teva | Mass | 1 |
Vincristine Teva | Mydriasis | 1 |
vincristine Teva | Neurotoxicity | 1 |
Vincristine Teva | Posterior reversible encephalopathy syndrome | 1 |
VINCRISTINE TEVA | Septic shock | 1 |
Vincristine Teva | Stupor | 1 |
Vincristine Teva | Unresponsive to stimuli | 1 |
VINCRISTINE TEVA 0.1 % (1 MG/ 1ML) | Administration site oedema | 1 |
VINCRISTINE TEVA 0.1 % (1 MG/ 1ML) | Extravasation | 1 |
VINCRISTINE TEVA 0.1 % (1 MG/ 1ML) | Injection site joint pain | 1 |
Vincristine-Teva | Drug-induced liver injury | 1 |
Total Records: 1,179 Number of Pages: 59